Revvity Inc.

Healthcare · Diagnostics & Research

151.10$ +0.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Revvity Inc. (RVTY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 730 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement RVTY
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	548	567	514	547	554	642	644	703	674	756	649	723	707	805	652	812	964	1,355	1,308	1,228	861	1,028	963	896	712	741	675	709	671	696	650	692	684	729	665	720	699	772	711	730	2,912
Cost of Revenue	297	301	285	300	296	348	373	384	366	404	365	400	391	435	376	395	469	553	556	580	373	482	368	344	361	395	293	307	298	402	295	306	299	370	289	328	324	434	323	313	1,395
Gross Profit	251	266	230	247	258	294	271	319	309	352	284	322	316	371	277	417	495	802	751	648	488	546	595	552	351	346	381	402	373	294	355	386	385	360	376	393	375	338	388	417	1,517
Research & Development	33	33	33	34	35	38	46	47	45	48	48	48	45	48	49	50	50	57	60	66	49	61	58	56	54	55	57	57	53	50	50	48	49	49	54	53	51	58	58	49	216
Selling, General & Administrative	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	334	261	243	244	251	269	251	252	262	254	239	239	250	250	242	252	254	280	1,028
Total Operating Expenses	164	179	165	167	144	239	218	220	213	224	216	223	221	226	201	243	246	280	273	300	220	239	314	306	231	195	286	291	279	195	281	284	282	227	303	302	293	226	312	328	1,158
Operating Income	86	87	65	80	115	55	53	99	96	128	68	99	96	145	76	174	250	522	478	348	269	307	280	245	120	151	96	111	93	99	74	102	103	132	72	91	82	112	76	89	359
Interest Expense	11	11	11	11	11	11	18	16	17	16	16	17	16	14	14	12	12	12	14	17	44	28	28	27	26	23	23	26	25	25	24	25	24	23	23	23	23	24	25	23	94
Pre-Tax Income	70	69	40	71	105	81	29	72	78	79	37	72	63	65	35	165	234	473	480	326	135	300	225	206	82	138	29	72	51	31	35	87	100	95	52	69	56	92	50	64	261
Income Tax Expense	12	6.9	3.9	8.1	8.5	119	2.5	7.0	2.6	8.1	1.3	2.7	4.6	0.7	1.0	28	57	93	101	80	27	116	41	45	13	31	4.6	13	18	-32	5.9	14	7.0	6.2	11	13	8.5	-6.8	9.1	10	21
Net Income	57	65	39	24	97	-83	26	65	77	71	35	69	59	65	34	137	177	380	379	246	108	190	177	179	70	138	569	36	9.6	103	28	79	94	95	42	55	47	98	41	52	238
EBITDA	107	105	76	106	142	122	91	132	140	143	103	142	133	137	109	236	308	549	565	418	230	441	363	342	191	265	161	206	184	162	167	219	232	222	173	194	181	218	180	189	767

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings